Table 2.

Effects on GSSG and GSH levels in tissues 30 min following NOV-002 treatment. Data are represented as the mean ± SEM

Tissue		GSH ng/ug	GSSG (ng/ug)
Liver	Control	29.9 ± 7.9	1.22 ± 0.19
	NOV-002	25.4 ±4.9	2.36 ± 0.35 * p= 0.01
Kidney	Control	6.8 ±0.6	0.29 ± 0.03
	NOV-002	11.5 ±1.5 * p=0.01	1.30 ± 0.32 * p= 0.01
Lung	Control	3.2 ±0.9	0.13 ± 0.01
	NOV-002	2.9 ±0.4	3.55 ± 1.00 * p= 0.005
Spleen	Control	14.6 ± 5.1	1.12 ± 0.19
	NOV-002	12.6 ± 1.9	5.41 ± 1.19 * p= 0.003